Q4 2024 Transmedics Group Inc Earnings Call Transcript

Feb 27, 2025 / 09:30 PM GMT

Release Date Price: $72.12 (-2.22%)

Transcript 10-K8-K

Key Points

Positve

TransMedics Group Inc (TMDX) reported a strong Q4 2024 with total revenue of $121.6 million, representing approximately 50% growth year over year.
The company's US revenue grew 11% sequentially to $117 million, showcasing strong domestic performance.
TransMedics Group Inc (TMDX) achieved an operating profit of $8.6 million in Q4, up from $3.9 million in Q3, indicating improved profitability.
The company reported an overall gross margin improvement to 59% in Q4, up from 56% in Q3.
TransMedics Group Inc (TMDX) expanded its fleet of owned aircraft to 21, enhancing its logistics capabilities and operational efficiency.

Negative

The company's overall gross margin for the full year 2024 was 59.4%, down from 63.8% in 2023, due to a higher contribution of service revenue which carries a lower margin.
TransMedics Group Inc (TMDX) faced allegations from a short report, which led to an investigation, although no evidence of fraud was found.
The company anticipates potential operational challenges in 2025, including unexpected aircraft maintenance impacting service margins.
There is variability in organ transplantation volumes, which could affect quarterly performance, as seen in Q3 2024.
The precise timing of launching the next-gen lung and heart clinical programs depends on several variables, including FDA approval timelines, which could impact growth projections.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

TMDX.OQ - Transmedics Group Inc
Q4 2024 Transmedics Group Inc Earnings Call
Feb 27, 2025 / 09:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good afternoon and welcome to the Transmedics 4th quarter and full year 2024 earnings conference call.

At this time, All participants are in a listen-only mode. We will be facilitating a question and answer session towards the end of today's call. To ask a question at that time, you may press then 1 on your telephone keypad. To withdraw your question, please press 2. As a reminder, this call is being recorded for replay purposes. I would now like to turn the call over to Lane Morgan from the Gil Martin Group for a few introductory comments. You may begin.

--------------------------------------------------------------------------------
Unidentified_2 [2]
----------------------------------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.